Related references
Note: Only part of the references are listed.Gliomas Infiltrating the Corpus Callosum: A Systematic Review of the Literature
Paolo Palmisciano et al.
CANCERS (2022)
Liquid Biopsy in Diagnosis and Prognosis of High-Grade Gliomas; State-of-the-Art and Literature Review
Lapo Bonosi et al.
LIFE-BASEL (2022)
La classification de l’OMS 2021 des tumeurs du système nerveux central
Dominique Figarella-Branger et al.
ANNALES DE PATHOLOGIE (2021)
Prognostic factors for glioblastoma patients - a clinical population-based study
B. Fekete et al.
ACTA NEUROLOGICA SCANDINAVICA (2016)
Implications of Mitogen-Activated Protein Kinase Signaling in Glioma
Vimal Pandey et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2016)
Stereotactic body radiotherapy in non-operable lung cancer patients
R. E. Vadala et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2016)
Therapeutic control and resistance of the EGFR-driven signaling network in glioblastoma
Francisco Azuaje et al.
CELL COMMUNICATION AND SIGNALING (2015)
Clinical impact of molecular biomarkers in gliomas
Tali Siegal
JOURNAL OF CLINICAL NEUROSCIENCE (2015)
A practical review of prognostic correlations of molecular biomarkers in glioblastoma
Michael Karsy et al.
NEUROSURGICAL FOCUS (2015)
Prognostic Factors in Lobar World Health Organization Grade II Astrocytomas
Mueez Waqar et al.
WORLD NEUROSURGERY (2015)
OPINION Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma
Frank B. Furnari et al.
NATURE REVIEWS CANCER (2015)
RTOG 0211: A Phase 1/2 Study of Radiation Therapy With Concurrent Gefitinib for Newly Diagnosed Glioblastoma Patients
Arnab Chakravarti et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Changes in presentation, treatment, and outcomes of adult low-grade gliomas over the past fifty years
Ryan S. Youland et al.
NEURO-ONCOLOGY (2013)
Current understanding of the role and targeting of tumor suppressor p53 in glioblastoma multiforme
Bryant England et al.
TUMOR BIOLOGY (2013)
Prolonged temozolomide for treatment of glioblastoma: preliminary clinical results and prognostic value of p53 overexpression
Nadia Malkoun et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Glioblastoma survival in the United States before and during the temozolomide era
Derek R. Johnson et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Analysis of EGFR, KRAS and P53 mutations in lung cancer using cells in the curette lavage fluid obtained by bronchoscopy
Fumihiro Yamaguchi et al.
LUNG CANCER (2012)
Pathology: Commonly Monitored Glioblastoma Markers: EFGR, EGFRvIII, PTEN, and MGMT
Joaquin Q. Camara-Quintana et al.
NEUROSURGERY CLINICS OF NORTH AMERICA (2012)
p53 Modulates Acquired Resistance to EGFR Inhibitors and Radiation
Shyhmin Huang et al.
CANCER RESEARCH (2011)
Phase 2 trial of erlotinib plus sirolimus in adults with recurrent glioblastoma
David A. Reardon et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
Phase II trial of bevacizumab and erlotinib in patients with recurrent malignant glioma
Sith Sathornsumetee et al.
NEURO-ONCOLOGY (2010)
Epidermal Growth Factor Receptor in Glioma: Signal Transduction, Neuropathology, Imaging, and Radioresistance
Kimmo J. Hatanpaa et al.
NEOPLASIA (2010)
Worse Outcome in Primary Glioblastoma Multiforme With Concurrent Epidermal Growth Factor Receptor and p53 Alteration
Yolanda Ruano et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2009)
Prognostic Significance of Molecular Markers and Extent of Resection in Primary Glioblastoma Patients
Joerg Felsberg et al.
CLINICAL CANCER RESEARCH (2009)
Molecular Predictors of Progression-Free and Overall Survival in Patients With Newly Diagnosed Glioblastoma: A Prospective Translational Study of the German Glioma Network
Michael Weller et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
Prognostic impact of molecular markers in a series of 220 primary glioblastomas
C Houillier et al.
CANCER (2006)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Prognostic factors for survival in adult patients with cerebral low-grade glioma
F Pignatti et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Share Paper
